Home › Compare › ECVTF vs MRK

ECVTF vs MRK: Dividend Comparison 2026

ECVTF yields 10.19% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ECVTF wins by $403.8K in total portfolio value
10 years
ECVTF
ECVTF
● Live price
10.19%
Share price
$17.88
Annual div
$1.82
5Y div CAGR
31.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$434.5K
Annual income
$194,842.90
Full ECVTF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — ECVTF vs MRK

📍 ECVTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodECVTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ECVTF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ECVTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ECVTF
Annual income on $10K today (after 15% tax)
$865.83/yr
After 10yr DRIP, annual income (after tax)
$165,616.47/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, ECVTF beats the other by $164,808.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ECVTF + MRK for your $10,000?

ECVTF: 50%MRK: 50%
100% MRK50/50100% ECVTF
Portfolio after 10yr
$232.6K
Annual income
$97,896.60/yr
Blended yield
42.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ECVTF
No analyst data
Altman Z
7.1
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ECVTF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricECVTFMRK
Forward yield10.19% ✓3.25%
Annual dividend / share$1.82$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR31.7% ✓8.2%
Portfolio after 10y$434.5K ✓$30.7K
Annual income after 10y$194,842.90 ✓$950.29
Total dividends collected$383.1K ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ECVTF vs MRK ($10,000, DRIP)

YearECVTF PortfolioECVTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,042$1,341.53$11,192$351.54+$850.00 → ECVTF
2$14,873$1,988.31$12,524$392.70+$2.3K → ECVTF
3$18,937$3,022.70$14,015$438.65+$4.9K → ECVTF
4$24,999$4,737.03$15,682$489.96+$9.3K → ECVTF
5$34,446$7,697.19$17,547$547.23+$16.9K → ECVTF
6$49,912$13,054.24$19,632$611.16+$30.3K → ECVTF
7$76,687$23,281.68$21,963$682.53+$54.7K → ECVTF
8$126,084$44,028.80$24,571$762.18+$101.5K → ECVTF
9$224,010$89,099.69$27,486$851.08+$196.5K → ECVTF
10$434,533$194,842.90$30,745$950.29+$403.8K → ECVTF

ECVTF vs MRK: Complete Analysis 2026

ECVTF — Stock

Economic Investment Trust Limited is a closed-ended equity mutual fund launched and managed by Burgundy Asset Management Ltd. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P/TSX Composite Index, MSCI World Index, and S&P 500 Index. Economic Investment Trust Limited was formed in January 28, 1927 and is domiciled in Canada.

Full ECVTF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this ECVTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ECVTF vs SCHDECVTF vs JEPIECVTF vs OECVTF vs KOECVTF vs MAINECVTF vs JNJECVTF vs ABBVECVTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.